SEDA Pharmaceutical Development Services

About SEDA Pharmaceutical Development Services

Seda Pharmaceutical Development Services provide Pharmaceutical Development and Clinical Pharmacology services and consultancy to the Pharma and Biotechnology Industry. We enable the rapid and efficient development of optimal medicinal products by providing coherent and synergistic support.

Our purpose is to provide the very highest levels of applied scientific expertise to ou...

  • Country/Region:
    United Kingdom
  • Founded:
    2015
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
Contract Research Organisation
Packaging & drug delivery
Contact info
  • Unit 4 Oakfield Road, Cheadle Royal Business Park, SK8 3GX, Cheadle, United Kingdom

Products from SEDA Pharmaceutical Development Services (3)

  • Analytical Development & Validation Services

    Product Analytical Development & Validation Services

    Seda provides comprehensive Analytical Development and Validation services to support pharmaceutical products from early development through clinical manufacture and regulatory submission.

    Our analytical scientists develop, optimise, validate, and transfer robust analytical methods that ensure p...
  • Clinical Pharmacology services

    Product Clinical Pharmacology services

    Seda  provides expert Clinical Pharmacology services to support informed decision-making from early clinical development through proof-of-concept studies.

    Our team combines clinical pharmacology expertise with advanced modelling and simulation capabilities to evaluate the relationship betwe...
  • Clinical Trial Manufacturing Services

    Product Clinical Trial Manufacturing Services

    Seda  provides GMP Clinical Trial Manufacturing services for pharmaceutical and biotechnology companies progressing products through early-phase clinical development.

    Our experienced manufacturing team delivers high-quality investigational medicinal products (IMPs) for Phase I and Phase II ...